- Bladder Cancer
- Breast Cancer
- Liver Cancer
- Cerebral Palsy
OTHERS RELATED TREATMENT
Breast Cancer Treatment
Breast cancer, cancer that are malignant -- life-threatening-tumors -- that develop in one or both breasts. The interior of the female breast, which consists mostly of fatty and fibrous connective tissues, is divided into about 20 sections called lobes. Each lobe is further subdivided into a collection of lobules, which are structures that contain small milk-producing glands. These glands secrete milk into a complex system of tiny ducts. The ducts carry the milk through the breast and converge in a collecting chamber located just below the nipple. Breast cancer is either invasive (spreading) or noninvasive (generally known as in situ -- that is, confined to the site of origin). Infiltrating ductal carcinoma, an invasive cancer, penetrates the wall of a duct, and is the most common form of breast cancer, constituting about 70% of all cases. Infiltrating lobular carcinoma, an invasive cancer that has spread through the wall of a lobule, accounts for about 8% of all breast cancers. It is much more likely to appear in both breasts, often in several separate locations. Noninvasive breast cancers include ductal carcinoma in situ (also called intraductal carcinoma) and lobular carcinoma in situ and account for about 10% of all cases. These cancers are termed noninvasive because at the time of diagnosis there is no evidence of invasion through the basement membrane, a layer separating the affected cells from the underlying connective tissue, which is rich in blood vessels. Ductal carcinoma in situ is considered to be an early malignancy; if left untreated, it may sometimes progress to an invasive, infiltrating ductal breast cancer. Lobular carcinoma in situ seems to be a marker for an increased risk of cancer in both breasts. In at least 20% of these cases, invasive cancer (often of the ductal variety) eventually develops, sometimes in a different location from the original lobular carcinoma in situ.
Who Gets Breast Cancer?
Early onset of menses and late menopause: Onset of the menstrual cycle prior to the age of 12 and menopause after 50 causes increased risk of developing breast cancer.
Diets high in saturated fat: The types of fat are important. Monounsaturated fats such as canola oil and olive oil do not appear to increase the risk of developing breast cancer like polyunsaturated fats; corn oil and meat.
Family history of breast cancer: Patients with a positive family history of breast cancer are at increased risk for developing the disease. However, 85% of women with breast cancer have a negative family history!
Family history only includes immediate relatives, mother, sisters and daughters. If a family member was post-menopausal (fifty or older) when she was diagnosed with breast cancer, the lifetime risk is only increased 5%. If the family member was premenopausal, the lifetime risk is 18.6%. If the family member was premenopausal and had bilateral breast cancer, the lifetime risk is 50%.
Genetic testing of the BRCA1 and BRCA2 genes is increasingly being integrated into clinical care for appropriately counseled adults who meet established criteria for this testing. The American Society of Clinical Oncologists (ASCO) and the National Comprehensive Cancer Network (NCCN) are among the professional healthcare organizations who have published criteria for genetic counseling/testing and cancer risk management. Increased and earlier surveillance, chemoprevention (tamoxifen, oral contraceptives) and surgical interventions (mastectomy, oophorectomy - removal of the ovaries and fallopian tubes) are among the current early detection and risk-reducing strategies discussed with women undergoing BRCA testing. In contrast to breast cancer, there is no reliable early detection for ovarian cancer, which is often fatal due to late stage at diagnosis. Therefore, oophorectomy is generally recommended between ages 35-40 or upon completion of childbearing for women at high risk for ovarian cancer. Despite initial concerns about insurance coverage discrimination, many insurers, including major indemnity plans (BC/BS, Aetna, Kaiser, etc.) recognize the healthcare benefits of this BRCA testing and cover test and genetic counsultation fees when demmed medically necessary. To date, more than 10,000 women and men have had BRCA testing. Similar to other medical tests, BRCA test results are often used to substantiate the need for the early detection and risk-reducing options available for individuals at high-risk for breast and ovarian cancers.
Late or no pregnancies: Pregnancies prior to the age of twenty-six are somewhat protective. Nuns have a higher incidence of breast cancer.
Moderate alcohol intake: Greater than two alcoholic beverages per day.
Estrogen replacement therapy: Most studies indicate that taking estrogen longer than ten years may lead to a slight increase in risk for developing breast cancer. However, these studies indicate that the positive benefits of taking estrogen as far as reducing the risk for osteoporosis, heart disease and now more recently Alzheimer's and colon cancer, far outweigh the slight increase in risk that may be associated with estrogen replacement therapy.
Caution should be exercised in those women with a significantly positive family history of breast cancer or atypical intraductal hyperplasia. Women with breast cancer are not currently give estrogen replacement. There are no scientific studies currently justifying this practice. However, until those studies are available, by convention, women are taken off estrogen.
History of prior breast cancer: Patients with a prior history of breast cancer are at increased risk for developing breast cancer in the other breast. This risk is 1% per year or a lifetime risk of 10%. The reason for close clinical follow-up after the diagnosis of breast cancer is not only to detect recurrence of the disease, but also to detect breast cancer in the opposite breast.
Female: The mere fact that being female increases the risk of developing breast cancer. However, for every 100 women with breast cancer, 1 male will develop the disease.
Therapeutic irradiation to chest wall i.e., for Hodgkins Disease (cancer of lymph nodes): Patients who have had therapeutic irradiation to the chest are at increased risk for developing breast cancer approximately 10 years later and consideration should be given to earlier screening in this population.
Moderate obesity: The relationship of breast cancer to obesity is more complex but associated with an increased risk. All these Breast Cancer can be treated with Chinese Master's herbal and acupuncture treatment if come early. Many that have Breast Cancer gets cured by Chinese Master special formulars.
|True Story: Acupuncture is the answer for Breast Cancer|
File No: 17294
Mdm M.K. Chan, 56 years old from Malaysia was diagnosed of 4th stage breast cancer. She started seeing Master on 9th April 2009 until 21 March 2013.
During her initial visit to The TOLE, she was advised to undergo intensive treatment for 4 months.
However, her condition deteriorates when she started tapering down the intake of herbs from initially 1 packet a day to 1 packet every 3 days for a few years. But, she is still surviving and goes to work daily.
After her previous consultant doctor at Gleneagles passed away, she stopped coming for treatment. Master thinks that she is giving up because she felt a lot for the famous oncology doctor.
Below table shows the result of her CEA test during the treatment period with THE TOLE: